Literature DB >> 7956418

Pharmacomechanical thrombolysis of experimental pulmonary emboli. Rapid low-dose intraembolic therapy.

V F Tapson1, P A Gurbel, L A Witty, K S Pieper, R S Stack.   

Abstract

We utilized low-dose intraembolic urokinase (UK) infusions in a canine model of experimental pulmonary embolism (PE) and compared the arteriographic extent of thrombolysis with three other treatment regimens. Group 1 animals (n = 16) received the intraembolic UK infused directly into the PE offering the mechanical effect of the infusion combined with pharmacologic thrombolysis. In the group 2 animals (n = 5), UK was delivered via a guide catheter placed proximal to the clot. Group 3 animals (n = 6) were treated with a direct intraembolic saline solution infusion. Group 4 (n = 7) received only intravenous heparin. The arteriographic extent of thrombolysis was graded 1+ to 3+. The extent of thrombolysis was 2.88+ in the group 1 animals and was significantly greater than in groups 2, 3, or 4 (p = 0.003, 0.0005, and 0.0001, respectively). Fibrinogen levels did not significantly decrease with intraembolic treatment (p = 0.07). Delivery of UK directly into emboli in an experimental canine PE model appears to elicit a combined mechanical and pharmacologic effect resulting in extensive thrombolysis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7956418     DOI: 10.1378/chest.106.5.1558

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

Review 1.  Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.

Authors:  Matthew A Chiarello; Akhilesh K Sista
Journal:  Semin Intervent Radiol       Date:  2018-06-04       Impact factor: 1.513

2.  Advances in the diagnosis and treatment of acute pulmonary embolism.

Authors:  Victor F Tapson
Journal:  F1000 Med Rep       Date:  2012-05-02

3.  Catheter-directed thrombolysis in a COVID-19 patient complicated with pulmonary embolism.

Authors:  Betul Balaban Kocas; Kadriye Kilickesmez
Journal:  Turk J Emerg Med       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.